Europe Cancer Vaccines Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 129
Inquire Before Buying

Notes:

Sales, means the sales volume of Cancer Vaccines

Revenue, means the sales value of Cancer Vaccines

This report studies sales (consumption) of Cancer Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Dendreon

- GlaxoSmithKline

- Merck

- Sanofi

- Vaccinogen

- Vaxon Biotech

- Vical

- Aduro BioTech

- Advantagene

- Advaxis

- Agenus

- AlphaVax

- Altor BioScience

- Amgen

- Antigen Express

- Argos Therapeutics

- Biothera

- Bristol-Myers Squibb

- Celldex Therapeutics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Vaccines in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Cancer Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Cancer Vaccines Market Report 2016

Table of Contents
Europe Cancer Vaccines Market Report 2016
1 Cancer Vaccines Overview
1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cancer Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Cancer Vaccines Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cancer Vaccines (2011-2021)
1.5.1 Europe Cancer Vaccines Sales and Growth Rate (2011-2021)
1.5.2 Europe Cancer Vaccines Revenue and Growth Rate (2011-2021)
2 Europe Cancer Vaccines by Manufacturers, Type and Application
2.1 Europe Cancer Vaccines Market Competition by Manufacturers
2.1.1 Europe Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Cancer Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Vaccines (Volume and Value) by Type
2.2.1 Europe Cancer Vaccines Sales and Market Share by Type (2011-2016)
2.2.2 Europe Cancer Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe Cancer Vaccines (Volume and Value) by Countries
2.3.1 Europe Cancer Vaccines Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Cancer Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cancer Vaccines (Volume) by Application
3 Germany Cancer Vaccines (Volume, Value and Sales Price)
3.1 Germany Cancer Vaccines Sales and Value (2011-2016)
3.1.1 Germany Cancer Vaccines Sales and Growth Rate (2011-2016)
3.1.2 Germany Cancer Vaccines Revenue and Growth Rate (2011-2016)
3.1.3 Germany Cancer Vaccines Sales Price Trend (2011-2016)
3.2 Germany Cancer Vaccines Sales and Market Share by Manufacturers
3.3 Germany Cancer Vaccines Sales and Market Share by Type
3.4 Germany Cancer Vaccines Sales and Market Share by Application
4 France Cancer Vaccines (Volume, Value and Sales Price)
4.1 France Cancer Vaccines Sales and Value (2011-2016)
4.1.1 France Cancer Vaccines Sales and Growth Rate (2011-2016)
4.1.2 France Cancer Vaccines Revenue and Growth Rate (2011-2016)
4.1.4 France Cancer Vaccines Sales Price Trend (2011-2016)
4.2 France Cancer Vaccines Sales and Market Share by Manufacturers
4.3 France Cancer Vaccines Sales and Market Share by Type
4.4 France Cancer Vaccines Sales and Market Share by Application
5 UK Cancer Vaccines (Volume, Value and Sales Price)
5.1 UK Cancer Vaccines Sales and Value (2011-2016)
5.1.1 UK Cancer Vaccines Sales and Growth Rate (2011-2016)
5.1.2 UK Cancer Vaccines Revenue and Growth Rate (2011-2016)
5.1.5 UK Cancer Vaccines Sales Price Trend (2011-2016)
5.2 UK Cancer Vaccines Sales and Market Share by Manufacturers
5.3 UK Cancer Vaccines Sales and Market Share by Type
5.4 UK Cancer Vaccines Sales and Market Share by Application
6 Russia Cancer Vaccines (Volume, Value and Sales Price)
6.1 Russia Cancer Vaccines Sales and Value (2011-2016)
6.1.1 Russia Cancer Vaccines Sales and Growth Rate (2011-2016)
6.1.2 Russia Cancer Vaccines Revenue and Growth Rate (2011-2016)
6.1.6 Russia Cancer Vaccines Sales Price Trend (2011-2016)
6.2 Russia Cancer Vaccines Sales and Market Share by Manufacturers
6.3 Russia Cancer Vaccines Sales and Market Share by Type
6.4 Russia Cancer Vaccines Sales and Market Share by Application
7 Italy Cancer Vaccines (Volume, Value and Sales Price)
7.1 Italy Cancer Vaccines Sales and Value (2011-2016)
7.1.1 Italy Cancer Vaccines Sales and Growth Rate (2011-2016)
7.1.2 Italy Cancer Vaccines Revenue and Growth Rate (2011-2016)
7.1.7 Italy Cancer Vaccines Sales Price Trend (2011-2016)
7.2 Italy Cancer Vaccines Sales and Market Share by Manufacturers
7.3 Italy Cancer Vaccines Sales and Market Share by Type
7.4 Italy Cancer Vaccines Sales and Market Share by Application
8 Spain Cancer Vaccines (Volume, Value and Sales Price)
8.1 Spain Cancer Vaccines Sales and Value (2011-2016)
8.1.1 Spain Cancer Vaccines Sales and Growth Rate (2011-2016)
8.1.2 Spain Cancer Vaccines Revenue and Growth Rate (2011-2016)
8.1.8 Spain Cancer Vaccines Sales Price Trend (2011-2016)
8.2 Spain Cancer Vaccines Sales and Market Share by Manufacturers
8.3 Spain Cancer Vaccines Sales and Market Share by Type
8.4 Spain Cancer Vaccines Sales and Market Share by Application
9 Benelux Cancer Vaccines (Volume, Value and Sales Price)
9.1 Benelux Cancer Vaccines Sales and Value (2011-2016)
9.1.1 Benelux Cancer Vaccines Sales and Growth Rate (2011-2016)
9.1.2 Benelux Cancer Vaccines Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Cancer Vaccines Sales Price Trend (2011-2016)
9.2 Benelux Cancer Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Cancer Vaccines Sales and Market Share by Type
9.4 Benelux Cancer Vaccines Sales and Market Share by Application
10 Europe Cancer Vaccines Manufacturers Analysis
10.1 Dendreon
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Cancer Vaccines Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Cancer Vaccines Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Merck
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Cancer Vaccines Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Sanofi
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Cancer Vaccines Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Vaccinogen
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Cancer Vaccines Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Vaxon Biotech
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Cancer Vaccines Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Vical
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Cancer Vaccines Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Aduro BioTech
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Cancer Vaccines Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Advantagene
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Cancer Vaccines Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Advaxis
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Cancer Vaccines Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Agenus
10.12 AlphaVax
10.13 Altor BioScience
10.14 Amgen
10.15 Antigen Express
10.16 Argos Therapeutics
10.17 Biothera
10.18 Bristol-Myers Squibb
10.19 Celldex Therapeutics
11 Cancer Vaccines Manufacturing Cost Analysis
11.1 Cancer Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Vaccines
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Cancer Vaccines Market Forecast (2016-2021)
14.1 Germany Cancer Vaccines Sales Forecast (2016-2021)
14.2 France Cancer Vaccines Sales Forecast (2016-2021)
14.3 UK Cancer Vaccines Sales Forecast (2016-2021)
14.4 Russia Cancer Vaccines Sales Forecast (2016-2021)
14.5 Italy Cancer Vaccines Sales Forecast (2016-2021)
14.6 Spain Cancer Vaccines Sales Forecast (2016-2021)
14.7 Benelux Cancer Vaccines Sales Forecast (2016-2021)
14.8 Europe Cancer Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe Cancer Vaccines Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Cancer Vaccines
Table Classification of Cancer Vaccines
Figure Europe Sales Market Share of Cancer Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Cancer Vaccines
Figure Europe Sales Market Share of Cancer Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure France Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Cancer Vaccines Sales Share by Manufacturers
Table Europe Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Vaccines Revenue Share by Manufacturers
Table 2016 Europe Cancer Vaccines Revenue Share by Manufacturers
Table Europe Cancer Vaccines Sales and Market Share by Type (2011-2016)
Table Europe Cancer Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Vaccines by Type (2011-2016)
Figure Europe Cancer Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe Cancer Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe Cancer Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Vaccines by Type (2011-2016)
Figure Europe Cancer Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe Cancer Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe Cancer Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cancer Vaccines by Countries (2011-2016)
Table Europe Cancer Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe Cancer Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cancer Vaccines by Countries (2011-2016)
Table Europe Cancer Vaccines Sales and Market Share by Application (2011-2016)
Table Europe Cancer Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Vaccines by Application (2011-2016)
Figure Germany Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Germany Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany Cancer Vaccines Sales Price Trend (2011-2016)
Table Germany Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Vaccines Sales by Type (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Type (2015 and 2016)
Table Germany Cancer Vaccines Sales by Application (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Application (2015 and 2016)
Figure France Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure France Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure France Cancer Vaccines Sales Price Trend (2011-2016)
Table France Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table France Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Cancer Vaccines Sales by Type (2015 and 2016)
Table France Cancer Vaccines Market Share by Type (2015 and 2016)
Table France Cancer Vaccines Sales by Application (2015 and 2016)
Table France Cancer Vaccines Market Share by Application (2015 and 2016)
Figure UK Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure UK Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure UK Cancer Vaccines Sales Price Trend (2011-2016)
Table UK Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Vaccines Sales by Type (2015 and 2016)
Table UK Cancer Vaccines Market Share by Type (2015 and 2016)
Table UK Cancer Vaccines Sales by Application (2015 and 2016)
Table UK Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Russia Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Russia Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia Cancer Vaccines Sales Price Trend (2011-2016)
Table Russia Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Vaccines Sales by Type (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Type (2015 and 2016)
Table Russia Cancer Vaccines Sales by Application (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Italy Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Italy Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy Cancer Vaccines Sales Price Trend (2011-2016)
Table Italy Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Vaccines Sales by Type (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Type (2015 and 2016)
Table Italy Cancer Vaccines Sales by Application (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Spain Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Spain Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain Cancer Vaccines Sales Price Trend (2011-2016)
Table Spain Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Vaccines Sales by Type (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Type (2015 and 2016)
Table Spain Cancer Vaccines Sales by Application (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux Cancer Vaccines Sales Price Trend (2011-2016)
Table Benelux Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Vaccines Sales by Type (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Type (2015 and 2016)
Table Benelux Cancer Vaccines Sales by Application (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Application (2015 and 2016)
Table Cancer Vaccines Basic Information List
Table Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Cancer Vaccines Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Cancer Vaccines Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Vaccines Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cancer Vaccines Sales Market Share (2011-2016)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaccinogen Cancer Vaccines Sales Market Share (2011-2016)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaxon Biotech Cancer Vaccines Sales Market Share (2011-2016)
Table Vical Basic Information List
Table Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Cancer Vaccines Sales Market Share (2011-2016)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aduro BioTech Cancer Vaccines Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Cancer Vaccines Sales Market Share (2011-2016)
Table Advaxis Basic Information List
Table Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advaxis Cancer Vaccines Sales Market Share (2011-2016)
Table Agenus Basic Information List
Table Agenus Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agenus Cancer Vaccines Sales Market Share (2011-2016)
Table AlphaVax Basic Information List
Table AlphaVax Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table AlphaVax Cancer Vaccines Sales Market Share (2011-2016)
Table Altor BioScience Basic Information List
Table Altor BioScience Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altor BioScience Cancer Vaccines Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Cancer Vaccines Sales Market Share (2011-2016)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Antigen Express Cancer Vaccines Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Biothera Basic Information List
Table Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biothera Cancer Vaccines Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Vaccines Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure Germany Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cancer Vaccines Sales Forecast by Type (2016-2021)
Table Europe Cancer Vaccines Sales Forecast by Application (2016-2021)
  • United States, EU, Japan, China, India and Southeast Asia Healthcare BPO Market Size, Status and Forecast 2021
    Published: 07-Dec-2016        Price: US 3300 Onwards        Pages: 109
    Notes: Production, means the output of Healthcare BPO Revenue, means the sales value of Healthcare BPO This report studies the global Healthcare BPO market, analyzes and researches the Healthcare BPO development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Quintiles - HCL - Cognizant - Covance - Accenture - Inventiv - C......
  • Global Telemedicine Market Professional Survey Report 2016
    Published: 07-Dec-2016        Price: US 3500 Onwards        Pages: 118
    Notes: Production, means the output of Telemedicine Revenue, means the sales value of Telemedicine This report studies Telemedicine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for e......
  • Global Contract Research Organization (CRO) Sales Market Report 2016
    Published: 07-Dec-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Contract Research Organization (CRO) Revenue, means the sales value of Contract Research Organization (CRO) This report studies sales (consumption) of Contract Research Organization (CRO) in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Quintiles - LabCorp ......
  • United States, EU, Japan, China, India and Southeast Asia Pharmacy Automation Market Size, Status and Forecast 2021
    Published: 05-Dec-2016        Price: US 3300 Onwards        Pages: 106
    Notes: Production, means the output of Pharmacy Automation Revenue, means the sales value of Pharmacy Automation This report studies the global Pharmacy Automation market, analyzes and researches the Pharmacy Automation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - BD - Baxter International - TOSHO - Takazono - Omnicell......
  • Global Interventional Oncology Device Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Interventional Oncology Device Revenue, means the sales value of Interventional Oncology Device This report studies sales (consumption) of Interventional Oncology Device in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Intranasal Corticosteroids Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Intranasal Corticosteroids Revenue, means the sales value of Intranasal Corticosteroids This report studies sales (consumption) of Intranasal Corticosteroids in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi - Johnson & Joh......
  • Global Interventional Oncology Devices Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Interventional Oncology Devices Revenue, means the sales value of Interventional Oncology Devices This report studies sales (consumption) of Interventional Oncology Devices in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Leukotriene Receptor Antagonist Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Leukotriene Receptor Antagonist Revenue, means the sales value of Leukotriene Receptor Antagonist This report studies sales (consumption) of Leukotriene Receptor Antagonist in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi ......
  • United States Drugs for Non-small Cell Lung Cancer Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Drugs for Non-small Cell Lung Cancer Revenue, means the sales value of Drugs for Non-small Cell Lung Cancer This report studies sales (consumption) of Drugs for Non-small Cell Lung Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Sanofi - ZIOPHARM Oncology......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs